From September 4 to 5, 2026, the 8th China Pharmaceutical Industry Expo (CMC Expo) was successfully held at the Suzhou International Expo Center. As a major event focused on innovation and high-quality development across the entire pharmaceutical industry chain, this year's conference brought together numerous pharmaceutical enterprises, research institutions, and upstream and downstream partners to discuss industry trends and growth opportunities.

Guangzhou Evidence-Based Medicine Technology Co., Ltd. (hereinafter referred to as "Guangzhou EBM") showcased its full-industry-chain TCM R&D service solutions at this year's CMC Expo, engaging in in-depth exchanges with industry experts, clients, and professional visitors, and comprehensively demonstrating its integrated capabilities and innovative practices in TCM R&D and evidence-based medicine services.

High Visitor Interest at the Booth, Evidence-Based Approach Draws Attention

During the expo, the Guangzhou EBM booth attracted many attendees who stopped by for consultations. The company's team highlighted six core business segments: CRO services, medical institution formulation transformation, drug regulatory registration, medical services, cultivation of major TCM products, and SMO services. Visitors showed strong interest in the company's "from R&D to market" full-chain service model for TCM products. On-site technical experts held in-depth discussions with clients on hot topics such as clinical trials of new TCM drugs, post-marketing re-evaluation, real-world studies, and human experience research.

A Decade of Industry Dedication, Empowering TCM Modernization

As the TCM industry advances toward high-quality development, the sector has raised higher requirements for clinical evidence, compliance pathways, and market value of products.

Since its establishment in 2016, Guangzhou EBM has been dedicated to providing high-quality full-industry-chain TCM R&D services. By highly integrating premium industry resources, the company ensures that every product's R&D—from design and execution to results—meets the requirements of being scientific, compliant, authentic, complete, efficient, and quality-controllable.

Deepening Cooperation, Jointly Promoting High-Quality Industry Growth

During the expo, the Guangzhou EBM team held productive exchanges with on-site clients on topics such as mining the clinical value of TCM products, market strategy planning, and industrialization challenges. This exhibition not only demonstrated the company's professional strength in the TCM CRO field but also further strengthened exchanges and cooperation with industry partners.

In the future, Guangzhou EBM will continue to uphold the philosophy of "Evidence-Based Modern Technology, Validating Chinese Wisdom," continuously empowering the cultivation and value enhancement of major TCM products through high-quality evidence-based research, and working hand in hand with industry partners to drive China's TCM industry toward a more scientific, efficient, and modern direction.